Metraipolis › archive › dc_9fbee2cfc450

From mechanisms to therapies: exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease — Europe PMC PMID:42181192

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42181192
DOI
10.3389/fendo.2026.1821507
License (as archived)
solo-consultazione
Archived
2026-11-02T15:46:31.586Z
SHA-256 of the archived text
92e82a00fd4e22bc90c00383deb260bbb049131b4381a307cf50c0cc828071c9
Stable URL of this page
https://metraipolis.com/documento/dc_9fbee2cfc450

How to cite

From mechanisms to therapies: exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease — Europe PMC PMID:42181192 — Europe PMC (en), https://europepmc.org/article/MED/42181192 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9fbee2cfc450 (Metraipolis archive dc_9fbee2cfc450, sha256 92e82a00fd4e22bc90c00383deb260bbb049131b4381a307cf50c0cc828071c9)
BibTeX
@misc{dc9fbee2cfc450,
  title = {From mechanisms to therapies: exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease — Europe PMC PMID:42181192},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181192},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9fbee2cfc450; sha256 92e82a00fd4e22bc90c00383deb260bbb049131b4381a307cf50c0cc828071c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181192. Agents can read the archived copy with the MCP tool read_document.